AstraZeneca fends off Pfizer with new growth plan
AstraZeneca on Tuesday outlined plans to make sales jump over the next decade, an effort to persuade shareholders the drug maker can do well as an independent company, rather than get bought out by rival Pfizer.
May 6, 2014
0
0